Monoclonal antibody therapy of human gliomas: current status and future approaches.
about
Novel tumor antigens identified by autologous antibody screening of childhood medulloblastoma cDNA librariesMRP3: a molecular target for human glioblastoma multiforme immunotherapy.Affinity-matured anti-glycoprotein NMB recombinant immunotoxins targeting malignant gliomas and melanomas.Development of an EGFRvIII specific recombinant antibodyHuman leukocyte differentiation antigens as therapeutic targets: the CD molecules and CD antibodies.Recent progress in immunotherapy for malignant glioma: treatment strategies and results from clinical trials.Chaperone proteins and brain tumors: potential targets and possible therapeutics.A limiting factor for the progress of radionuclide-based cancer diagnostics and therapy--availability of suitable radionuclides.Small molecule and monoclonal antibody therapies in neurooncology.Chemotherapy for malignant glioma.Stage-specific embryonic antigen-4 as a potential therapeutic target in glioblastoma multiforme and other cancers.Passive immunotherapeutic strategies for the treatment of malignant gliomas.A monoclonal antibody targeted against epidermal growth factor receptor variant III enhances cisplatin efficiency.Value of surveillance imaging in the management of medulloblastoma.Purification of clinical-grade disulfide stabilized antibody fragment variable--Pseudomonas exotoxin conjugate (dsFv-PE38) expressed in Escherichia coli.Activity of anti-epidermal growth factor receptor monoclonal antibody C225 against glioblastoma multiforme.
P2860
Q28178383-090280DB-79CC-4530-82CC-832325FA3C5BQ30988770-DEBF1186-F015-479D-A68D-1292D5E48671Q33687487-1A99A14E-F9CF-4276-9353-5BB6A1FAF703Q33711627-BF317BBC-F17C-4004-A03B-5B4DD488B4CAQ34451956-73FBAE56-FF01-4791-9AB2-6F809E91FFC6Q35778581-545A55AB-C7E7-4487-B70B-1B1E2CDB5B9AQ35800492-C2010E5F-1538-4C55-A5A0-C64F8D5B3CF0Q35831439-D3545412-3F56-4C17-9CAF-2399FF32E0C1Q36108621-D599EA0B-4105-4DB5-BE74-A1418C3FCC1FQ36307802-1BA5058F-9ED9-40D3-B371-60BB863AAFEFQ37599805-4E41C77A-BE60-421A-B784-91E1496A5AEDQ37714783-AB764F6C-1DD5-452B-A2CD-113DDC3CE606Q39496576-97006321-3B90-4B91-BA8E-9975C0999CD2Q52936968-13B05932-F347-4AD5-9D8F-269D01FA6391Q54330353-C6D12D2C-4EEB-4830-984C-9BBFE266AE51Q55473253-1191A132-BFE0-4B42-BA55-06D22D14C2F4
P2860
Monoclonal antibody therapy of human gliomas: current status and future approaches.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Monoclonal antibody therapy of human gliomas: current status and future approaches.
@ast
Monoclonal antibody therapy of human gliomas: current status and future approaches.
@en
type
label
Monoclonal antibody therapy of human gliomas: current status and future approaches.
@ast
Monoclonal antibody therapy of human gliomas: current status and future approaches.
@en
prefLabel
Monoclonal antibody therapy of human gliomas: current status and future approaches.
@ast
Monoclonal antibody therapy of human gliomas: current status and future approaches.
@en
P2093
P356
P1476
Monoclonal antibody therapy of human gliomas: current status and future approaches.
@en
P2093
Sampson JH
Wikstrand CJ
P2888
P304
P356
10.1023/A:1006354102377
P577
1999-01-01T00:00:00Z
P6179
1047037905